ClassID:

20969

A61K38/204 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Cytokines; Lymphokines; Interferons; Interleukins [IL] IL-6

Recent Application in this class:
#1
20260102521
2026-04-16

METHODS AND SYSTEMS FOR IMPROVED NUCLEIC ACID DELIVERY VIA ULTRASOUND

#2
20260083818
2026-03-26

System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein

#3
20260060984
2026-03-05

Recombinant Viral Particle for Gene and/or Cellular Therapy

#4
20260041755
2026-02-12

ALPHAVIRUS T CELL EPITOPES, MEGAPOOLS AND USES THEREOF

#5
20260041717
2026-02-12

METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME

#6
20250339524
2025-11-06

COMBINATION ANTI-4-1BB IMMUNOTHERAPY, RADIOTHERAPY, AND B CELL ACTIVATION THERAPY

#7
20250339476
2025-11-06

ENGINEERED BACTERIAL THERAPEUTICS FOR THE TREATMENT OF GASTROINTESTINAL DISEASE

#8
20250325629
2025-10-23

METHODS OF PREPARATION OF SECRETOMES, AND USES THEREOF

#9
20250281575
2025-09-11

METHODS FOR THE TREATMENT OF DIABETES-ASSOCIATED AUTONOMIC NEUROPATHY

#10
20250241963
2025-07-31

PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT

#11
20250195648
2025-06-19

THERAPEUTIC COMPOSITION AND METHOD COMBINING MULTIPLEX IMMUNOTHERAPY WITH CANCER VACCINE FOR THE TREATMENT OF CANCER

#12
20250188146
2025-06-12

Modified Cell Expansion and Uses Thereof

#13
20250177455
2025-06-05

NOVEL THERAPEUTIC COMPRISING A SECRETOME FROM MESENCHYMAL STEM CELLS OF UMBILICORD TISSUE OR WHARTON'S JELLY

#14
20250073272
2025-03-06

PRODUCTION OF ENHANCED STEM CELL-BASED EXOSOMES AND USES IN SCAR TISSUE PREVENTION AND TREATMENT

#15
20250073163
2025-03-06

METHOD FOR TREATING INFECTIOUS DISEASE

#16
20250049889
2025-02-13

NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF

#17
20250011400
2025-01-09

METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SEVERE INFLUENZA

#18
20250009900
2025-01-09

OXAZAPHOSPHORINE ANTIBODY DRUG CONJUGATES AND METHODS OF USE

#19
20250000913
2025-01-02

SALMONELLA ENGINEERED FOR NONTOXIC COLONIZATION OF TUMORS

#20
20240415932
2024-12-19

Systems and Methods for Angiogenic Treatment in Wound Healing

#21
20240382562
2024-11-21

METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS

#22
20240299448
2024-09-12

METHODS FOR PREVENTING AND TREATING CHRONIC PAIN

#23
20240285831
2024-08-29

METHODS OF USE OF MODULATORS TO IMPROVE NERVE REGENERATION

#24
20240269236
2024-08-15

METHODS OF TREATING AGE-RELATED FRAILTY WITH INTERLEUKIN-6

#25
20240269187
2024-08-15

ISOLATION AND USE OF HUMAN LYMPHOID ORGAN-DERIVED SUPPRESSIVE STROMAL CELLS

#26
20240269175
2024-08-15

COMPOSITIONS AND METHODS OF CELLULAR IMMUNOTHERAPY

#27
20240226329
2024-07-11

BACTERIAL TARGETING VECTOR CARRYING CYTOKINE OR POLYNUCLEOTIDE THEREOF AND USE THEREOF IN TUMOR TREATMENT

#28
20240226266
2024-07-11

METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS

#29
20230364218
2023-11-16

METHODS AND COMPOSITIONS FOR PRODUCING AN ADENOVIRUS VECTOR FOR USE WITH MULTIPLE VACCINATIONS

#30
20230364054
2023-11-16

METHODS FOR TREATING COVID-19

#31
20230330183
2023-10-19

STEM CELL CONDITIONED MEDIA FOR CLINICAL AND COSMETIC APPLICATIONS

#32
20230321190
2023-10-12

PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING SECRETOMES

#33
20230293636
2023-09-21

PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF POST-SURGICAL PAIN

#34
20230293630
2023-09-21

Coronavirus T Cell Epitopes and Uses Thereof

#35
20230263743
2023-08-24

NANOPARTICLE COMPLEX WITH DEFINED SIZES

#36
20230241122
2023-08-03

CRANIAL NEUROPATHY THERAPEUTIC AGENT CONTAINING CULTURE SUPERNATANT FOR UMBILICAL CORD BLOOD MONOCYTIC CELLS

#37
20230070595
2023-03-09

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

#38
20230032871
2023-02-02

Recombinant Viral Particle for Gene and/or Cellular Therapy

#39
20220395488
2022-12-15

Methods for treating COVID-19

#40
20220370593
2022-11-24

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

#41
20220339257
2022-10-27

METHODS TO INCREASE THE SENSITIVITY AND REVERSING THE RESISTANCE TO DRUGS

#42
20220331403
2022-10-20

METHODS AND COMPOSITIONS FOR INDUCING DIFFERENTIATION OF HUMAN BROWN ADIPOCYTE PROGENITORS

#43
20220275062
2022-09-01

Methods and compounds for the treatment or prevention of severe influenza

#44
20220265809
2022-08-25

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

#45
20220257761
2022-08-18

Therapeutic composition and method combining multiplex immunotherapy with cancer vaccine for the treatment of cancer

#46
20220249613
2022-08-11

CELL CULTURE FOR TREATING DISEASE IN THE LOWER LIMBS

#47
20220249575
2022-08-11

FORMULATION AND TREATMENT FOR OPHTHALMIC DISORDERS

#48
20220218874
2022-07-14

COMPOSITIONS AND METHODS OF MODULATING ENDOCHONDRAL OSSIFICATION AND BONE FORMATION

#49
20220202855
2022-06-30

Monocyte compositions and methods for the treatment of infectious disease

#50
20220193232
2022-06-23

KAPPA MYELOMA ANTIGEN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

#51
20220105157
2022-04-07

Compositions and Methods for Promoting Angiogenesis in the Eye

#52
20220008534
2022-01-13

Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer

#53
20220008514
2022-01-13

COMBINED USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND HEMATOPOIETIC GROWTH FACTORS FOR TREATING HEMATOPOIETIC DISEASES

#54
20210401897
2021-12-30

METHOD OF MANUFACTURING DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET AND DIABETIC FOOT PATIENT-SPECIFIC DERMAL REGENERATION SHEET MANUFACTURED USING THE SAME

#55
20210379021
2021-12-09

METHOD FOR PREPARING AND DELIVERING BISANTRENE FORMULATIONS

#56
20210353683
2021-11-18

ADDITIVE FOR MEDIUM FOR PROMOTING PRODUCTION OF PARACRINE FACTOR

#57
20210338778
2021-11-04

METHODS FOR TREATMENT OF MICROBIAL DISORDERS

#58
20210332126
2021-10-28

ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS

#59
20210299218
2021-09-30

NEUROPROTECTIVE COMPOSITIONS AND USE THEREOF

#60
20210260111
2021-08-26

METHODS FOR GENERATING MACROPHAGES WITH ENHANCED CANCER PHAGOCYTOSIS

#61
20210244668
2021-08-12

Particles for delivery of proteins and peptides

#62
20210138039
2021-05-13

PAIN RESPONSE MEDIATOR COMPOSITIONS AND METHODS FOR MAKING AND USING SAME

#63
20210106651
2021-04-15

BIO-MIMETIC FORMULATION

#64
20210077532
2021-03-18

Modified cell expansion and uses thereof

#65
20210046161
2021-02-18

SKIN OINTMENT FOR TREATING LABIA MINORA SKIN

#66
20200376095
2020-12-03

MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMES

#67
20200330557
2020-10-22

USES OF PD-1/PD-L1 INHIBITORS AND/OR CTLA-4 INHIBITORS WITH A BIOLOGIC CONTAINING MULTIPLE CYTOKINE COMPONENTS TO TREAT CANCER

#68
20200330556
2020-10-22

Methods for administering STING agonists

#69
20200323960
2020-10-15

Pharmaceutical compositions comprising oncostatin m (OSM) antagonist derivatives and methods of use

#70
20200316169
2020-10-08

System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein

#71
20200276245
2020-09-03

Catalyst for the regeneration of tissues and related method for making it

#72
20200268858
2020-08-27

Glaucoma treatment

#73
20200261565
2020-08-20

Methods and compositions for producing an adenovirus vector for use with multiple vaccinations

#74
20200237873
2020-07-30

Systems and methods for angiogenic treatment in wound healing

#75
20200140539
2020-05-07

ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ANEMIA

#76
20200138942
2020-05-07

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

#77
20200054580
2020-02-20

Methods of treating a neurological or psychiatric disorder

#78
20200010547
2020-01-09

Combination of an anti-CD16A antibody with a cytokine

#79
20190388476
2019-12-26

COMPOSITIONS AND METHODS FOR TREATING AND REPAIRING TENDONS

#80
20190365819
2019-12-05

Compositions for biological systems and methods for preparing and using the same

#81
20190359692
2019-11-28

Methods and compounds for the treatment or prevention of severe influenza

#82
20190358364
2019-11-28

Compositions and methods of modulating endochondral ossification and bone formation

#83
20190316153
2019-10-17

Packaging cell for making a pseudotyped lentivirus

#84
20190314411
2019-10-17

Modified cell expansion and uses thereof

#85
20190270779
2019-09-05

Re-directed immunotherapy

#86
20190255151
2019-08-22

Mesenchymal stem cells expressing anti-inflammatory cytokines and methods of use

#87
20190224277
2019-07-25

BIO-MIMETIC FORMULATION

#88
20190209650
2019-07-11

METHOD TO IMPROVE THE EFFECTIVENESS OF ANTI-CANCER THERAPIES BY EXPOSING CANCER CELLS TO AN INFLAMMATORY STIMULUS PRIOR TO TREATMENT

#89
20190192577
2019-06-27

Postpartum cells derived from placental tissue, and methods of making and using the same

#90
20190153383
2019-05-23

Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell

#91
20190151362
2019-05-23

Compositions and methods of cellular immunotherapy

#92
20190134089
2019-05-09

Methods for generating macrophages with enhanced cancer phagocytosis

#93
20190099471
2019-04-04

Methods for reducing severity of pulmonary fibrosis

#94
20190023780
2019-01-24

ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS

#95
20190022389
2019-01-24

System and method for treating inflammation

#96
20190017024
2019-01-17

Methods for inducing migration by dendritic cells and an immune response

#97
20180338999
2018-11-29

Soft tissue repair and regeneration using postpartum-derived cells and cell products

#98
20180318398
2018-11-08

METHODS AND COMPOSITIONS USING AMPK ACTIVATORS FOR PHARMACOLOGICAL PREVENTION OF CHRONIC PAIN

#99
20180289805
2018-10-11

Early cancer detection and enhanced immunotherapy

#100
20180271985
2018-09-27

Neurotherapeutic nanoparticle compositions comprising leukemia inhibitory factor

#101
20180264044
2018-09-20

Compositions for biological systems and methods for preparing and using the same

#102
20180228892
2018-08-16

Kappa myeloma antigen chimeric antigen receptors and uses thereof

#103
20180214547
2018-08-02

TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND IL-6

#104
20180195050
2018-07-12

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#105
20180185448
2018-07-05

COMPOSITION AND METHOD FOR INDUCING ANTI-INFLAMMATORY RESPONSE

#106
20180179555
2018-06-28

Methods of delivering a pseudotyped lentivirus

#107
20180104186
2018-04-19

METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA

#108
20180078635
2018-03-22

Vaccine formulation, preparation method therefor and use thereof

#109
20180055926
2018-03-01

Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

#110
20180022800
2018-01-25

Method for treating chronic intestinal inflammation and inflammatory bowel disease by administering antagonists of Oncostatin-M (OSM) and/or antagonists of OSM receptor-beta (OSMR)

#111
20180008673
2018-01-11

Treatment of right ventricular dysfunction due to pressure overload

#112
20170333539
2017-11-23

Anti-IL-6 vaccine composition

#113
20170326183
2017-11-16

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#114
20170246216
2017-08-31

Human amniotic fluid preparation having long-term stability

#115
20170239299
2017-08-24

Postpartum cells derived from placental tissue, and methods of making and using the same

#116
20170232076
2017-08-17

Mannose-6-phosphate bearing peptides fused to lysosomal enzymes

#117
20170216366
2017-08-03

Conditioned medium obtained from placental mesenchymal stem cells and use thereof in the therapeutic treatment of preeclampsia

#118
20170189496
2017-07-06

USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL

#119
20170182100
2017-06-29

Conditioned medium of liver progenitor cells

#120
20170166864
2017-06-15

Postpartum cells derived from placental tissue, and methods of making and using the same

#121
20170166863
2017-06-15

Postpartum cells derived from placental tissue, and methods of making and using the same

#122
20170143770
2017-05-25

Soft tissue repair and regeneration using postpartum-derived cells and cell products

#123
20170136089
2017-05-18

COMPOSITIONS AND METHODS OF REGULATING BONE RESORPTION

#124
20170087213
2017-03-30

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, immunoglobulins and chemotactic factors

#125
20170080030
2017-03-23

COMPOSITIONS AND METHODS FOR TREATING RETINOPATHY

#126
20170065706
2017-03-09

HPV vaccines and methods of use thereof

#127
20170065693
2017-03-09

Breast cancer vaccines and methods of use thereof

#128
20170000853
2017-01-05

WOUND HEALING COMPOSITION

#129
20160361388
2016-12-15

METHOD AND COMPOSITION FOR THE TREATMENT OF MODERATE TO SEVERE KERATOCONJUNCTIVITIS SICCA

#130
20160361386
2016-12-15

Methods and compositions for inducing differentiation of human brown adipocyte progenitors

#131
20160340692
2016-11-24

Recombinant retrovirus pseudotyped with E2 alphavirus glycoprotein

#132
20160324898
2016-11-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

#133
20160317583
2016-11-03

ENCAPSULATED STEM CELLS FOR THE TREATMENT OF INFLAMMATORY DISEASE

#134
20160303198
2016-10-20

Method of immunotherapy for treatment of human papillomavirus infection

#135
20160250163
2016-09-01

Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms

#136
20160106862
2016-04-21

Re-directed immunotherapy

#137
20160089420
2016-03-31

Activated leukocyte conditioned supernatant and uses for wound healing

#138
20150374757
2015-12-31

Compositions and methods for treating and repairing tendons

#139
20150368337
2015-12-24

Anti-IL-6 antibodies for the treatment of oral mucositis

#140
20150366953
2015-12-24

Glaucoma treatment

#141
20150361157
2015-12-17

Sgp130/Fc dimers

#142
20150306058
2015-10-29

COMPOSITION COMPRISING A SINGLE VARIABLE DOMAIN AND CAMOSTAT MESYLATE (CM)

#143
20150299215
2015-10-22

Spiro ring compound as hepatitis C virus (HCV) inhibitor and uses thereof

#144
20150297568
2015-10-22

Hepatitis C virus inhibitors

#145
20150290318
2015-10-15

Combination of local and systemic immunomodulative therapies for melanoma and liver cancer

#146
20150290165
2015-10-15

Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancer

#147
20150284409
2015-10-08

Hepatitis C virus inhibitors

#148
20150250868
2015-09-10

Re-directed immunotherapy

#149
20150250823
2015-09-10

Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour

#150
20150231266
2015-08-20

Neurotherapeutic Nanoparticle Compositions and Devices

#151
20150175976
2015-06-25

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#152
20150175962
2015-06-25

Generating hepatocytes

#153
20150164994
2015-06-18

Systems and methods for angiogenic treatment in wound healing

#154
20150164993
2015-06-18

Pharmaceutical composition having preventative or treatment effect on inflammatory bowel diseases

#155
20150159136
2015-06-11

Methods for inducing migration by dendritic cells and an immune response

#156
20150147292
2015-05-28

NOVEL SURFACE MARKERS FOR ADIPOSE TISSUE

#157
20150125422
2015-05-07

Hepatitis C virus inhibitors

#158
20150118184
2015-04-30

Anti-LAMP5 antibody and utilization thereof

#159
20150086508
2015-03-26

Method for increasing the expression of anti-microbial peptides by keratinocytes comprising administering a composition comprising IL-17, TNF-alpha and OSM

#160
20150071877
2015-03-12

Bioactive compositions and methods for their preparation and use

#161
20150064133
2015-03-05

Bioactive compositions derivable from platelet concentrates, and methods for preparing and using same

#162
20150051441
2015-02-19

Embryo implantation

#163
20150050298
2015-02-19

Isolation and use of human lymphoid organ-derived suppressive stromal cells

#164
20150037303
2015-02-05

CELLS, COMPOSITIONS, AND TREATMENT METHODS FOR STIMULATION OF HEMATOPOIESIS

#165
20150023908
2015-01-22

Skin cream

#166
20150017122
2015-01-15

CONDITIONED MEDIUM OBTAINED FROM PLACENTAL MESENCHYMAL STEM CELLS AND USE THEREOF IN THE THERAPEUTIC TREATMENT OF PREECLAMPSIA

#167
20150010497
2015-01-08

Combination of growth factors, cytokines, antibacterial/antiviral factors, stem cell stimulating factors, complement proteins C3A/C4A, and chemotactic factors

#168
20140348783
2014-11-27

Vaccine immunotherapy for treating cervical cancer in immune suppressed patients

#169
20140348782
2014-11-27

Vaccine immunotherapy for treating lymphoma in immune suppressed patients

#170
20140341846
2014-11-20

METHODS OF INHIBITING PHOTORECEPTOR APOPTOSIS

#171
20140322161
2014-10-30

Method for treating chronic colitis and systemic sclerosis and for eliciting a protective immune reaction against human IL-6

#172
20140308240
2014-10-16

Therapeutic agent for infections, and treatment method using same

#173
20140205564
2014-07-24

Hepatitis C Virus Inhibitors

#174
20140205563
2014-07-24

Compositions derived from stem cell released molecules and methods for formulation thereof

#175
20140178378
2014-06-26

sgp130/Fc dimers for treatment of inflammatory disease

#176
20140127156
2014-05-08

Hepatitis C virus inhibitors

#177
20140030217
2014-01-30

Vaccine immunotherapy

#178
20140017195
2014-01-16

Hepatitis C virus inhibitors

#179
20140010780
2014-01-09

Vaccine immunotherapy for treating hepatocellular cancer in immune suppressed patients

#180
20140010779
2014-01-09

VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

#181
20140004081
2014-01-02

Re-directed immunotherapy

#182
20130266537
2013-10-10

Moesin modulators and uses thereof

#183
20130243724
2013-09-19

Compositions and methods for inducing migration by dendritic cells and an immune response

#184
20130243723
2013-09-19

Vaccine immunotherapy

#185
20130230485
2013-09-05

Methods for Treating Patients Undergoing Multi-Cycle Chemotherapy

#186
20130224148
2013-08-29

Activated leukocyte conditioned supernatant and uses for wound healing

#187
20130224144
2013-08-29

Sequential administration of a replication defective adenovirus vector in vaccination protocols

#188
20130202553
2013-08-08

Mobilization of hematopoietic stem cells

#189
20130171097
2013-07-04

Method for the prophylactic or therapeutic treatment of glucocorticoid-induced osteoporosis

#190
20130149280
2013-06-13

Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation

#191
20130142754
2013-06-06

Hepatitis C virus inhibitors

#192
20130129671
2013-05-23

Tripeptides Incorporating Deuterium as Inhibitors of Hepatitis C Virus

#193
20130115190
2013-05-09

Hepatitis C virus inhibitors

#194
20130052159
2013-02-28

METHODS FOR TREATMENT OF MICROBIAL DISORDERS

#195
20130022585
2013-01-24

Regeneration and repair of neural tissue using postpartum-derived cells

#196
20130011366
2013-01-10

Therapeutic Agent for infections, and treatment method using the same

#197
20130004457
2013-01-03

Hepatitis C virus inhibitors

#198
20120308517
2012-12-06

COMPOSITIONS FOR THE TREATMENT OF INFECTIOUS AND TUMOURAL DISEASES

#199
20120263677
2012-10-18

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

#200
20120244117
2012-09-27

Method of immunotherapy for treament of human papillomavirus infection

#201
20120244115
2012-09-27

Treating non-hematopoietic cancer with interleukin 6

#202
20120225029
2012-09-06

Skin cream

#203
20120207705
2012-08-16

Stem Cell Conditioned Medium Compositions

#204
20120189629
2012-07-26

Anti-IL-6 antibodies for the treatment of oral mucositis

#205
20120178164
2012-07-12

Treating cardiovascular tissue

#206
20120172305
2012-07-05

RETRO-INVERSO PEPTIDES DERIVED FROM INTERLEUKIN-6

#207
20120164180
2012-06-28

Method of identifying tumor associated antigens

#208
20120142755
2012-06-07

COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION

#209
20120128626
2012-05-24

Anti-IL-6 antibodies for the treatment of anemia

#210
20120121579
2012-05-17

TREATMENT OF ONCOSTATIN M RECEPTOR BETA MEDIATED HEART FAILURE

#211
20120107953
2012-05-03

Stabilization of interleukin 6 in serum based solutions

#212
20120070462
2012-03-22

Targeted gene delivery to dendritic cells

#213
20120064035
2012-03-15

Vaccine immunotherapy

#214
20120034268
2012-02-09

Bacterial ghosts for mediating innate immunity

#215
20120009143
2012-01-12

Inhibiting non-hematopoietic cancer with interleukin 6

#216
20110300097
2011-12-08

Method And Composition For The Treatment Of Moderate To Severe Keratoconjunctivitis Sicca

#217
20110293562
2011-12-01

USE OF CARDIOTROPHIN-1 FOR THE TREATMENT OF METABOLIC DISEASES

#218
20110293559
2011-12-01

CATABOLIC AGENTS

#219
20110293527
2011-12-01

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#220
20110280828
2011-11-17

METHODS FOR TREATMENT OF MICROBIAL DISORDERS

#221
20110274647
2011-11-10

IL6R/IL6 chimera for therapy of chemotherapy-induced peripheral neuropathy

#222
20110262387
2011-10-27

METHODS AND MATERIALS FOR REDUCING OR SUPPRESSING AMYLOID DEPOSITION

#223
20110236431
2011-09-29

TREATMENT OF ACUTE MYOCARDIAL INFARCTION (AMI) USING ENCAPSULATED CELLS ENCODING AND SECRETING GLP-1 PEPTIDES OR ANALOGS THEREOF

#224
20110217261
2011-09-08

Combination pharmaceutical agents as inhibitors of HCV replication

#225
20110195047
2011-08-11

ONCOSTATIN M AS PROMOTER OF IMMUNOSTIMULATORY ACTIVITY OF HUMAN EPITHELIAL CELLS

#226
20110182850
2011-07-28

ORGANIC COMPOUNDS AND THEIR USES

#227
20110129439
2011-06-02

Conditioned medium of liver progenitor cells

#228
20110110884
2011-05-12

IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

#229
20110076249
2011-03-31

IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

#230
20110070269
2011-03-24

LIPOPOLYSACCHARIDE ISOLATED FROM PYRULARIA TISSUE AND/OR PYRULARIA-ASSOCIATED BACTERIA AND USES THEREOF

#231
20110039790
2011-02-17

Enhanced ocular neuroprotection and neurostimulation

#232
20110021422
2011-01-27

Method and compositions for prevention and treatment of diabetic and aged skin

#233
20110021413
2011-01-27

Methods of suppressing microglial activation

#234
20110020311
2011-01-27

Therapy of neurological inflammatory diseases with (5'-deoxy-5'-adenosyl) cobamamide, recombinant human growth hormone, interleukins IL-1, IL-6, IL-11, epidermal growth factor, and physiotherapy

#235
20110020274
2011-01-27

Mobilization of hematopoietic stem cells

#236
20110008281
2011-01-13

Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia

#237
20110002883
2011-01-06

THERAPEUTIC PREPARATIONS CONTAINING WHARTON'S JELLY

#238
20100316607
2010-12-16

Hepatitis C virus inhibitors

#239
20100310469
2010-12-09

VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

#240
20100286072
2010-11-11

Retro-inverso peptides derived from interleukin-6

#241
20100266591
2010-10-21

METHOD OF TREATING ERYTHROPOIETIN HYPORESPONSIVE ANEMIAS

#242
20100260843
2010-10-14

Regeneration and repair of neural tissue using postpartum-derived cells

#243
20100226878
2010-09-09

Methods of inhibiting photoreceptor apoptosis

#244
20100215616
2010-08-26

Hepatitis C virus inhibitors

#245
20100210013
2010-08-19

Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

#246
20100189684
2010-07-29

Use of gp130 activators in diabetic neuropathy

#247
20100183673
2010-07-22

Sequential administration of a replication defective adenovirus vector in vaccination protocols

#248
20100183542
2010-07-22

Synergism Between Activated Immune Cells and Conventional Cancer Therapies

#249
20100166703
2010-07-01

Use of IL-6/IL-6 chimera in Huntington's disease

#250
20100135952
2010-06-03

Methods for the treatment of renal failure

#251
20100120140
2010-05-13

Recombiant lentivirus comprising an E2 alphavirus glycoprotein that binds to DC-SIGN

#252
20100120122
2010-05-13

Packaging cells for producing retrovirus pseudotyped with an E2 alphavirus glycoprotein

#253
20100047205
2010-02-25

Vaccine immunotherapy

#254
20100028367
2010-02-04

sgp130/Fc dimers

#255
20100008907
2010-01-14

Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor

#256
20090304625
2009-12-10

MODULATORS OF CARDIAC CELL HYPERTROPHY AND HYPERPLASIA

#257
20090300776
2009-12-03

COMPOSITIONS FOR PREVENTING, REDUCING OR TREATING KERATINOCYTE-MEDIATED INFLAMMATION

#258
20090274651
2009-11-05

Therapeutic agent for infections, and treatment method using the same

#259
20090227489
2009-09-10

STAT3 Agonists and Antagonists and Therapeutic Uses Thereof

#260
20090214494
2009-08-27

Cancer Vaccines and Therapeutic Methods

#261
20090214466
2009-08-27

Methods of Alleviating Disorders and Their Associated Pain

#262
20090202475
2009-08-13

Compositions and methods for treatment of microbial disorders

#263
20090185997
2009-07-23

Methods of suppressing microglial activation and systemic inflammatory responses

#264
20090180982
2009-07-16

VACCINE IMMUNOTHERAPY FOR IMMUNE SUPPRESSED PATIENTS

#265
20090169614
2009-07-02

METHODS OF SUPPRESSING MICROGLIAL ACTIVATION AND SYSTEMIC INFLAMMATORY RESPONSES

#266
20090169506
2009-07-02

USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY

#267
20090162426
2009-06-25

Use of a Compound with RANKL Activity

#268
20090155287
2009-06-18

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#269
20090143282
2009-06-04

ENHANCED RECOVERY FOLLOWING OCULAR SURGERY

#270
20090104146
2009-04-23

Compositions for enhancing keratinocyte migration and epidermal repair via a receptor containing OSMRβ as a subunit, and applications thereof

#271
20090098529
2009-04-16

Methods for attenuating virus strains for diagnostic and therapeutic uses

#272
20090076481
2009-03-19

Therapeutic angiogenesis for treatment of the spine

#273
20090074712
2009-03-19

Methods for Treatment and Prevention of Infection

#274
20090068140
2009-03-12

Hepatitis C virus inhibitors

#275
20090053244
2009-02-26

Modified vaccinia virus strains for use in diagnostic and therapeutic methods

#276
20090053168
2009-02-26

TREATMENTS OF B-CELL PROLIFERATIVE DISORDERS

#277
20090047242
2009-02-19

CONDITIONED BLOOD COMPOSITION AND METHOD FOR ITS PRODUCTION

#278
20090035281
2009-02-05

COMBINATION OF INTERLEUKIN-6 ANTAGONISTS AND ANTIPROLIFERATIVE DRUGS

#279
20090022684
2009-01-22

Methods for hematopoietic stimulation

#280
20080274098
2008-11-06

Method of treating or preventing tissue deterioration, injury or damage due to a neuro-, muscular- or neuro-muscular-degenerative disease, or restore tissue adversely affected by said disease

#281
20080274077
2008-11-06

Method for Treating Neurological Disorders

#282
20080233088
2008-09-25

PREPARATIVE REGIMEN FOR ENGRAFTMENT, GROWTH AND DIFFERENTIATION OF NON-HEMATOPOEITIC CELLS IN VIVO AFTER TRANSPLANTATION

#283
20080213214
2008-09-04

Compositions consisting essentially of TGF-β, BMP-2 FGF-4, leukemia inhibitory factor, IGF-1, IL-6 and H-α-thrombin

#284
20080193409
2008-08-14

Compositions and methods for therapy or prevention of chemotherapy-induced neuropathy

#285
20080175911
2008-07-24

Compositions and methods for soft tissue repair

#286
20080146506
2008-06-19

Methods of suppressing microglial activation

#287
20080108579
2008-05-08

ENHANCED OCULAR NEUROPROTECTION AND NEUROSTIMULATION

#288
20080107625
2008-05-08

Inhibitors of Hepatitis C Virus

#289
20080107621
2008-05-08

Method for inhibiting a microvascular complication by administering IL-6

#290
20080102101
2008-05-01

ENHANCED RECOVERY FOLLOWING OCULAR SURGERY

#291
20080102055
2008-05-01

Method for detecting candidate alzheimer's disease drug

#292
20080090765
2008-04-17

Compositions for modulating growth of embryonic and adult kidney tissue and uses for treating kidney damage

#293
20080070830
2008-03-20

Homing of cells to myocardium

#294
20080025945
2008-01-31

Use of IL-6 in liver injury

#295
20080019998
2008-01-24

Targeted gene delivery for dendritic cell vaccination

#296
20080014187
2008-01-17

Compositions and Methods for Treating Hypertension and Inflammation

#297
20070243160
2007-10-18

REMEDIES FOR NERVE DAMAGES

#298
20070212392
2007-09-13

Chemoprevention of endometrial cancer

#299
20070191276
2007-08-16

Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors

#300
20070172464
2007-07-26

Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same